期刊文献+

姜黄素对6-羟基多巴胺诱导的帕金森病模型的神经保护作用及机制研究 被引量:7

Neuroprotective effect and mechanism of curcumin on Parkinson disease model induced by 6-OHDA
下载PDF
导出
摘要 目的探讨姜黄素对6-羟基多巴胺(6-OHDA)诱导的PD大鼠模型的精神保护作用及作用机制。方法应用6-OHDA分别建立帕金森病(PD)动物模型和细胞模型。从行为学角度(旋转实验),观察姜黄素预处理对6-OHDA制备的PD模型大鼠的保护作用并通过观察各组细胞线粒体跨膜电位、细胞活性氧物质(ROS)以及检测细胞中Caspase-3的含量变化初步探讨其作用机制。结果 1动物模型:PD模型组大鼠旋转圈数明显增加(平均316 r/30 min),与空白组(0 r/30 min)相比,差异有统计学意义(P<0.05)。应用姜黄素预处理后,大鼠旋转圈数明显减少(206 r/30 min),与PD模型组相比,差异有统计学意义(P<0.05)。2细胞模型:姜黄素可以通过抗氧化应激的作用对多巴胺能神经细胞阻断由6-OHDA所导致的细胞线粒体跨膜电位(Δψm)的下降,抑制细胞内ROS水平;也可以通过抗凋亡的作用减轻Caspase-3的活化。结论姜黄素对6-OHDA制备的PD大鼠模型具有保护作用,可能是通过抗氧化应激、抗凋亡等机制来发挥保护作用。 Objective To study the neuroprotective effect and mechanism of curcumin on 6-OHDA-induced Parkinson's disease(PD) rat model. Methods Rat model and cell model of PD were established by 6-OHDA. From the behavioral point of view(rotation experiment), the protective effect of curcumin pretreated 6-OHDA PD rat model was observed and the mechanism of curcumin was explored through observing the cell mitochondrial membrane potential, cellular reactive oxygen species and the content change of Caspase-3 cells in each group of cells. Results ① Rat model: PD rat model group significantly increased the number of slewing ring(an average of 316 r/30 min), compared with the blank control group(0 r/30 min), and the difference was significant(P〈 0.05). Rats with curcumin pretreatment had significantly decreased slewing rings(206 r/30 min), and compared with the PD model group, the difference was significant(P〈 0.05). ② Cell model: Curcumin on 6-OHDA processing MES 23.5 dopaminergic cells blocked the Δψm drop caused by 6-OHDA, which can resist to oxidative stress, inhibit intracellular ROS levels and reduced the activation of the Caspase-3 by antiapoptotic effect. Conclusion Curcumin plays a protective role in 6-OHDA-induced PD rat model. Its mechanism may be the resistance to oxidative stress and antiapoptotic mechanisms.
作者 李晓波 徐芳
出处 《中南药学》 CAS 2015年第1期34-37,共4页 Central South Pharmacy
关键词 姜黄素 6-羟基多巴胺 细胞凋亡蛋白酶-3 帕金森病 curcumin 6-OHDA Caspase-3 Parkinson disease
  • 相关文献

参考文献9

  • 1Masuda T,Hidaka K,Shimohara A,et al.Chemical studies on antioxidant mechanism of curcuminoid:analysis of radical reaction products from curcumin[J].J Agric Food Chem,1999,47,71.
  • 2刘兆金,黄瑞林,印遇龙,李铁军.姜黄素的营养生理作用综述[J].安徽农业科学,2006,34(7):1287-1288. 被引量:11
  • 3Blum D,Torch S,Lambeng N,et al.Molecular pathways involved in the neurotoxicity of 6-OHDA,dopamine and MPTP:contribution to the apoptotic theory in Parkinson’s disease[J].Prog Neurobiol,2001,65(2):135-172.
  • 4Lotharius J,Dugan LL,O’Malley KL.Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons[J].J Neurosci,1999,19(4):1284-1293.
  • 5Whitnall M,Richardson DR.Iron:a new target for pharmacological intervention in neurodegenerative diseases[J].Semin Pediatr Neurol,2006,13(3):186-197.
  • 6Barnham KJ,Masters CL,Bush AI.Neurodegenerative diseases and oxidative stress[J].Nat Rev Drug Discov,2004,3(3):205-214.
  • 7Lotharius J,Brundin P.Pathogenesis of Parkinson’s disease:dopamine,vesicles and alpha-synuclein[J].Nat Rev Neurosci,2002,3(12):932-942.
  • 8Susin SA,Daugas E,Ravagnan L,et al.Two distinct pathways leading to nuclear apoptosis[J].J Exp Med,2000,192(4):571-580.
  • 9Dong J,Song N,Xie J,et al.Ghrelin antagonized 1-methyl-4-phenylpyridinium MPP(+)-induced apoptosis in MES 23.5cells[J].J Mol Neurosci,2009,37(2):182-189.

二级参考文献22

共引文献10

同被引文献96

  • 1Vogel H G,Vogel W H.药理学实验指南-新药发现和药理学评价[M].杜冠华,李学军,张永祥,译.北京:科学出版社,2001:267-325.
  • 2Chaudhuri KR,Schapira AHV.Non-motor symptoms of Parkinson's disease:dopaminergic pathophysiology and treatment[J].Lancet Neurol,2009,8(5):464-474.
  • 3Rodriguez-Perez AI,Dominguez-Meijide A,Lanciego JL,et al.Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson's disease[J].Neurobiol Dis,2013,58:209-219.
  • 4Labandeira-Garcia JL,Rodriguez-Pallares J,DominguezMeijide A,et al.Dopamine-angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease[J].Movement Disorders,2013,28(10):1337-1342.
  • 5Mu?oz A,Garrido-Gil P,Dominguez-Meijide A,et al.Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease.Involvement of vascular endothelial growth factor and interleukin-1β[J].Exp Neurol,2014,261:720-732.
  • 6杨维娜,史利利,钱亦华,等.缬沙坦对阿尔茨海默病小鼠脑组织氧化应激及认知功能障碍的影响[C]//中国解剖学会2012年年会论文文摘汇编,2012:67.
  • 7Garrido-Gil P,Valenzuela R,Villar-Cheda B,et al.Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra:an intracellular renin-angiotensin system in the nigra[J].Brain Struct Funct,2013,218(2):373-388.
  • 8Wu L,Tian YY,Shi JP,et al.Inhibition of endoplasmic reticulum stress is involved in the neuroprotective effects of candesartan cilexitil in the rotenone rat model of Parkinson's disease[J].Neurosci Lett,2013,548:50-55.
  • 9Moradganjeh A,Ziai SA,Roghani M.Losartan pretreatment reduces neurodegeneration and behavioural symptoms in 6-hydroxydopamine induced unilateral rat model of Parkinson's disease[J].Pathophysiology,2013,20(4):243-248.
  • 10Ongali B,Nicolakakis N,Tong X K,et al.AngiotensinⅡtype 1 receptor blocker losartan prevents and rescues cerebrovascular,neuropathological and cognitive deficits in an Alzheimer's disease model[J].Neurobiol Dis,2014,68:126-136.

引证文献7

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部